Haloperidol For Vomiting
Haloperidol for Vomiting is a pharmacological intervention involving the use of haloperidol, a dopamine D2 receptor antagonist, distinguished by its application in the management of nausea and vomiting, particularly in palliative and chemotherapy-induced contexts where conventional antiemetics may be ineffective.
16
Publications
694
Citations
69
Authors
30
Institutions
Publications per year
2017–2026
4
Parents
16
Steven M. Grunberg, Kirit Gala, M Lampenfeld et al. · Journal of Clinical Oncology · 1984 · 76 citations
Roger M. Cole, Frances Robinson, Len Harvey et al. · Journal of Pain and Symptom Management · 1994 · 49 citations · Full text
1–5 of 16
69
2
h-index
2
h-index
2
h-index
1
h-index
1 publications · 76 citations
1
h-index
1–5 of 69
30

The University of Adelaide
Adelaide, Australia
2 h-index
2 publications
67 citations

Cornell University
Ithaca, United States
2 h-index
2 publications
36 citations

Augusta University
Augusta, United States
1 h-index
1 publications
10 citations
St. Vincent's Medical Center
Jacksonville, United States
1 h-index
1 publications
26 citations
Pediatrics and Genetics
Alpharetta, United States
1 h-index
1 publications
42 citations

Lankenau Medical Center
Philadelphia, United States
1 h-index
1 publications
42 citations

New York Hospital Queens
New York, United States
1 h-index
1 publications
26 citations
Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, Italy
1 h-index
2 publications
216 citations
1–8 of 30
Repository · 2 publications · 41 citations
2
h-index
2 publications · 67 citations
2
h-index
1 publications · 76 citations
1
h-index
1 publications · 73 citations
1
h-index
1 publications · 10 citations
1
h-index
1–5